Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Dual Responsive Hydroxyapatite Capped Mesoporous Silica Nanoparticles for Controlled Delivery of Palbociclib to Treat Osteosarcoma Publisher



Heydari SR1 ; Samadi M1 ; Shirangi A2 ; Farokhi M3 ; Moradi A1 ; Bafkary R1 ; Atyabi F1 ; Mottaghitalab F2 ; Dinarvand R1, 2
Authors

Source: Journal of Drug Delivery Science and Technology Published:2023


Abstract

Palbociclib (PB) is a selective cyclin-dependent kinase 4 and 6 inhibitor that have been approved for treatment of osteosarcoma. In this study, dual responsive mesoporous silica nanoparticles (MSNs) were designed to effectively deliver PB to osteosarcoma cancer cells. MSNs were modified with disulfide bonds and capped with hydroxyapatite (HA) to sense the changes of glutathione and pH, respectively. The size of the prepared NPs was around 250 nm as obtained from dynamic light scattering (DLS) and transmission electron microscopy (TEM). The drug loading of the NPs was 51% and 83.6% of the drug was released in an acidic pH and glutathione-rich environment, resembling a tumor are. Higher toxicity against MG-63 cells were obtained by PB loaded MSNs compared to PB alone. Moreover, confocal microscopy displayed high internalization of the NPs into osteosarcoma cells. The PB loaded MSNs also effectively induced the apoptosis in the cells (43%) and inhibited cellular proliferation in comparison to MSNs (28.47%) and control (13.08%). PB loaded HA –capped MSNs showed higher drug release in the tumor microenvironment and enhanced cytotoxicity against cancer cells. © 2023 Elsevier B.V.
Other Related Docs
13. An Overview of Biomedical Applications for Gold Nanoparticles Against Lung Cancer, Journal of Drug Delivery Science and Technology (2023)
17. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)